These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8145238)

  • 1. The novel Ins(1,4,5)P3 analogue 3-amino-3-deoxy-Ins(1,4,5)P3: a pH-dependent Ins(1,4,5)P3 receptor partial agonist in SH-SY5Y neuroblastoma cells.
    Kozikowski AP; Fauq AH; Wilcox RA; Challiss RA; Nahorski SR
    J Med Chem; 1994 Mar; 37(6):868-72. PubMed ID: 8145238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
    Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR
    FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
    Safrany ST; Sawyer DA; Nahorski SR; Potter BV
    Chirality; 1992; 4(7):415-22. PubMed ID: 1334423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
    Lu PJ; Gou DM; Shieh WR; Chen CS
    Biochemistry; 1994 Sep; 33(38):11586-97. PubMed ID: 7918372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
    Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
    FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of D-myoinositol 1,4,5-trisphosphate and synthetic 6-deoxy D-myoinositol 1,4,5-trisphosphate: binding and calcium release activity in rat parotid microsomes.
    Bonis D; Sezan A; Mauduit P; Dubreuil D; Cleophax J; Gero SD; Rossignol B
    Biochem Biophys Res Commun; 1991 Mar; 175(3):894-900. PubMed ID: 1850995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
    Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS; Beecroft MD; Riley AM; Jenkins DJ; Marwood RD; Taylor CW; Potter BV
    Biochemistry; 1997 Oct; 36(42):12780-90. PubMed ID: 9335535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two calcium-binding sites mediate the interconversion of liver inositol 1,4,5-trisphosphate receptors between three conformational states.
    Marshall IC; Taylor CW
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):591-8. PubMed ID: 8043006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between inositol tris- and tetrakis-phosphates. Effects on intracellular Ca2+ mobilization in SH-SY5Y cells.
    Gawler DJ; Potter BV; Gigg R; Nahorski SR
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):163-7. PubMed ID: 1645528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy.
    Beecroft MD; Marchant JS; Riley AM; Van Straten NC; Van der Marel GA; Van Boom JH; Potter BV; Taylor CW
    Mol Pharmacol; 1999 Jan; 55(1):109-17. PubMed ID: 9882704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.
    Schäfer R; Nehls-Sahabandu M; Grabowsky B; Dehlinger-Kremer M; Schulz I; Mayr GW
    Biochem J; 1990 Dec; 272(3):817-25. PubMed ID: 2176480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.